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Prion diseases are fatal neurodegenerative disorders caused by accumulation of abnormal
prion protein (protease-resistant prion, PrPres). PrPres accumulation is also detected in lym-
phoid organs after peripheral infection. Several studies suggest that follicular dendritic cells
(FDC) could be the site of PrPres retention and amplification.
Here we show that human follicular dendritic cells can express normal cellular prion pro-
tein (PrPc) both in situ and in vitro. When tonsillar cryosections were treated with anti-PrP
antibody, the label was found on some very delicate cell extensions inside the lymphoid folli-
cles, especially in the germinal centres. These extensions react with DRC antibody, used fre-
quently to label FDC. Other structures labelled with anti-PrP antibody were the keratinocytes.
To confirm the ability of FDC to synthesise PrPc, we isolated FDC by a non-enzymatic
procedure and cultured them. By cytochemistry and flow cytometry it was clearly shown that
FDC do produce PrPc.
Keywords: Follicular Dendritic Cells (FDC), germinal centre, human tonsil, immunolabelling, prion pro-
tein (PrPc)
INTRODUCTION
Prion diseases are characterised by accumulation of
infectious particles of protease-resistant prion
(PrPres) (Prusiner et al., 1982). This pathological iso-
form results from modification of normal cellular pro-
tein called PrPc. This protein is widely distributed in
the brain and other organs notably in the lymphoretic-
ular system.
The symptoms of prion diseases always occur after
accumulation of PrPres in the nervous system, leading
to observable pathological lesions. After peripheral
infection, however, PrPres is detected during the
pre-clinical stages in the spleen and other lymphoid
organs. Abundant PrPres was recently detected,
before the appearance of the clinical signs of the dis-
ease, in the germinal centres of tonsils (Hill et al.,
1997) and appendixes (Hilton et al., 1998) from
patients affected with nvCJD.
The prion diseases are now widely studied in
experimental models. Inoculation of PrPres into
wild-type mice induces the different symptoms,
whereas injection into PrP-deficient mice leads nei-
ther death nor to infectivity. This demonstrates the
major role played by PrPc (Bueler et al., 1993).
Results obtained with immunodeficient mouse
models show that lymphoid organs are involved in
various steps of disease development after peripheral
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inoculation (Cesbron et al., 1998; Aucouturier et al.,
1999). It is not clear, however, which immune system :II ::
cells play a key role in pathogenicity. Spleen fraction-
ation studies have shown that infectivity is associated
with the stromal fraction and with lymphocytes
(Clarke and Kimberlin, 1984; Raeber et al., 1999).
The incubation period in peripherally infected mice is
unaffected by whole body irradiation (Fraser and Far-
quhar, 1987). Thus, the prion replication depends on
PrPc and notably on a radiation-resistant fraction of
the cell population of lymphoid tissues. Follicular
dendritic cells (FDC) belong to this radio-resistant
fraction and are stromal cells (Kinet-Deno61 et al.,
1982). SCID mice lacking functional B and T cells
and also functional FDC are resistant to peripheral
infection by scrapie agent but develop the disease
after a bone marrow reconstitution (Fraser et al.,
1996). Reconstitution restores the presence of mature
T and B cells and induces differentiation of functional
follicular dendritic cells (Kapasi et al., 1993).
Immunohistochemical staining with anti-PrP anti-
bodies reveals an extraordinary accumulation of PrPres
in the lymphoid follicles, especially in the form of a
delicate network (Kitamoto et al., 1991; McBride et al.,
1992; Klein et al., 1998; Jeffrey et al., 1999). These
results strongly suggest that the follicular dendritic
cells might support scrapie agent accumulation and
replication in the peripheral lymphoid organs.
Herein the aim was to determine whether human
FDC can express PrPc. At this end, we have immu-
nolabelled cryosections of human tonsils. Further-
more, since FDC are located solely in the germinal
centres in intimate contact with B cells, we isolated
them and analysed their capacity to react with
anti-PrP antibodies just after purification and after
several days of culture. We report here that human
FDC do indeed synthesize PrPc.
RESULTS
FIGURE Immunolabelling of tonsillar follicular dendritic cells
with MoAb: DRC-1 Counterstaining with haematoxylin (x 100)
extensions was intensely labelled (Fig. 1). After
anti-PrP immunolabelling of cryosections with 3F4
antibody, the keratinocytes lining the crypts mainly at
the level of basal cells were stained densely as it was
previously reported by Pammer (Pammer et al.,
1998), however, the germinal centres displayed a very
low labelling. In the germinal centres, fine peroxidase
reagent deposits were found along the intercellular
spaces of the constituent cells (Fig. 2 A-B-C).
Control cryosections, reacted with normal mouse
serum instead of anti-PrP antibody then with StrepAB
Complex HRP and AEC didn’t display any deposit in
the germinal centres or along the crypts.
FDC In Situ Freshly Isolated FDC
On sections stained with MoAb:DRC1, a well-known
marker of follicular dendritic cells, the network of cell
FDC prepared by enzymatic digestion or mechanical
dissociation showed engulfment of germinal centreFDC CAN EXPRESS PRPC 261
FIGURE 2 Immunolabelling of tonsillar cryosections with MoAb:
3F4. Counterstaining with haematoxylin. (A) Keratinocytes of the
germinal layer in the crypts are positive (x 100). (B) Without coun-
terstaining, a weak positive pattern is detected inside the germinal
centre (x 650). (C) Besides the fine FDC extensions labelling, some
stained cells (arrows) localised in the germinal centre present the
morphology of tingible body macrophages (large binucleated
cells)(x 650)
lymphoid cells by their cytoplasmic extensions. FDC
always surrounded 3 to 20 lymphoid cells. These
FDC-clusters could easily be distinguished from lym-
phocyte aggregates, vascular or epithelial fragments
and tingible body macrophages. A strong positive
reaction with DRC1 antibody was found on the cyto-
plasmic projections of these FDC, which were fre-
quently bi-or multinucleated (Fig. 3).
PrPc expression was detected only on FDC-clusters
isolated without enzymatic treatment. Weak staining
with MoAbs:3F4, 3B5 and 12F10 was observed on
the cytoplasmic projections of the FDC (Fig. 4 A-B).
The percentage and intensity of positive FDC-clus-
ters depended to some degree on the monoclonal anti-
body used; 12F10 and 3F4 were recommended.262 CAROLINE THIELEN et al.
FIGURE 3 Immunostaining of freshly isolated FDC-cluster with
MoAb: DRC 1. Counterstaining with haematoxylin. DRC labelled
cytoplasmic extensions surround numerous lymphocytes (x 400)
FIGURE 5 Immunostaining of 4 days-old cultured FDC with
MoAbs: 12F10 (A) or 8G8 (B). Counterstaining with haematoxy-
lin. During culture, FDC attach to the substrate and emit thin cyto-
plasmic extensions which are PrPc positive (x 650)
FIGURE 4 Immunostaining of FDC-cluster freshly isolated with-
out enzyme with MoAbs: 3F4 (A) or 3B5 (B). Counterstaining with
haematoxylin. Note the presence of a weak positivity on dendritic
processes (x 400)
Cultured FDC
During several hours of primary culture, the FDC
extended thin cytoplasmic processes and adhered to
the plastic surface. The engulfed lymphocytes eventu-
ally died by apoptosis. These FDC showed no prolif-
erative activity and possessed one to ten nuclei.
After 4 days in culture, most of FDC reacted with
12F10 and 8G8 monoclonal antibodies in immunola-
belling experiments (Fig. 5 A-B). Expression of PrPc
was detected over the entire cell surface. Staining
appeared more intense than when freshly prepared
FDC-clusters were used.
PrPc expression was also analysed by cytometry on
FDC cultured for 6 days. Since FDC in vitro adhere to
the substrate, it was necessary to use trypsine toFDC CAN EXPRESS PRPC 263
0
10 101
A
1C 10 101’ 10 2" 10 3’ 1.04
Negative control
FDC fleshly detached with trypsine
FDC trypsinated and cultivated for
15h in cell suspended conditions
FIGURE 6 with MoAbs: 3B5 (A) and 848 (B). PrPc expression on 6 days-old cultured FDC analysed by cytometry
detach them. The intensity of PrPc expression on
freshly trypsinised FDC was low for both 3B5 and
8G8 monoclonal antibodies. To confirm that the FDC
synthesise PrPc, we cultivated the trypsinised FDC in
cell suspension conditions for an additional 15 h. This
procedure allowed a re-expression of PrPc by FDC
(Fig. 6 A-B). PrPc was detected with both antibodies
and labelling was intense as with Jurkat cells (Fig. 7).
DISCUSSION
In vivo findings of this and other laboratories (Kita-
moto et al., 1991; McBride et al., 1992; Klein et al.,
1998) indicate the presence of PrPc in low quantity
along the cytoplasmic extensions of follicular den-
dritic cells. Since FDC make intimate contact with
lymphoid cells and since lymphoid cells express PrPc
(Cashman et al., 1999; Mabbott et al., 1997; Dodelet
and Cashman, 1998), these findings do not constitute
conclusive evidence that FDC synthesise PrPc.
In the present study, we thus chose to work on FDC
isolated from human tonsils. We isolated the FDC in
two different ways: by enzyme treatment and
mechanical disruption. The former method has the
disadvantage of removing PrPc from the surface of
the FDC, as shown here and with Jurkat cells (data
not shown). The latter method yielded FDC-clusters
in which the FDC did appear to express PrPc on their
surface. The problem with these results is again the
presence of lymphocytes entrapped in the dendritic
processes of the FDC, leaving open the possibility
that the PrPc might actually be synthesized by the
lymphocytes, then transferred to the FDC.
The question was thus: can FDC produce PrPc by
themselves? To answer this question, we cultured
these isolated FDC-clusters so as to eliminate all
engulfed lymphocytes. In the culture system devel-
oped previously in this laboratory, FDC adhere to the
culture substrate. The FDC stretch out and take a
fibroblastic-like morphology. The lymphocytes even-
tually disappear by apoptosis so that only flat, firmly
attached FDC remain in the culture system. On these
attached FDC, we again detected PrPc by immunohis-
tochemistry. Secondly, to analyse these cultured FDC
by cytometry, we detached them with the aid of tryp-
sine. Since this treatment removes the surface PrPc,
as seen by cytometry and as reported by Caughey264 CAROLINE THIELEN et al.
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FIGURE 7 PrPc expression by Jurkat cells analysed by cytometry after MoAbs: 3B5 (line) or 8G8 (bold line) staining. Negative controls
with a non-specific murine Ig-Per-Cys (dotted line)
(Caughey et al., 1988,), we further cultured the
detached FDC in cell suspension to give them time to
synthesise PrPc and express it at their surface. The
cultured FDC were PrPc-positive in absence of any
lymphoid cells or stimulant. Thus, FDC appear to
express PrPc independently of any stimulation or
interaction with other cells. It is notheworthy that cul-
tured lymphoid cells can also synthesise PrPc. Anto-
ine et al. (submitted) working on cultured and freshly
isolated tonsillar cells observed by cytometry higher
surface expression of PrPc on the former than on the
latter. Thus, in vitro expression of PrPc is independent
of cell activation and may be related to stress or to
loss of the in vivo microenvironment. In this work,
furthermore, we observed different reactions accord-
ing to the antibody used. These differences might
reflect epitope accessibility related to protein folding
or its glycosylation.
By long-term culturing of FDC, we have thus
shown that these cells can express PrPc. In the future,
this model will enable us to study PrPres replication
and infectivity in FDC in vitro.
MATERIALS AND METHODS
Isolation and Purification of FDC-clusters
Palatine tonsils were surgically removed from chil-
dren aged 3 to 10. FDC-clusters were isolated by two
different procedures, enzymatically for culturing and
non-enzymatically for immunostaining on cytospins.
Enzymatic digestion method was described else-
where (Tsunoda et al., 1990); the tonsils were cut in
slices (1 mm thick) and digested for 20 min at 37C
with an enzyme cocktail containing 0.1% colla-
genase (Type A, Boehringer-Mannheim), 0.05 % dis-
pase ii (Grade II, Boehringer-Mannheim), 0.06 %
DNase I (Grade II, Boehringer-Mannheim) in PBS
with 0.4 % Bovine Serum Albumin (BSA). The
freed-cells fraction was stored in cold PBS with 0.4 %
BSA. The remaining tissues were digested again with
fresh enzyme solution.
For non-enzymatic dissociation, we chose gross
dissection and mechanical disruption of lymphoid fol-
licles. After the enucleating the follicles under ana-FDC CAN EXPRESS PRPC 265
tomical microscope, we squeezed them between two
glass slides to obtain a cell suspension composed
mainly of germinal-centre cells. The cell preparation
was filtrated on gauze to eliminate collagen bundles
and blood vessels. The whole procedure was carded
out in PBS + 0.4 % BSA at 4C.
After both cell dissociation procedures, the prepa-
rations were enriched in FDC-clusters by repetitive
1G sedimentation through Fetal Calf Serum (FCS)
(Wekede et al., 1980). FDC-clusters were finally
enriched at approximately 96% (v/v ratio).
FDC Culture
The final FDC-cluster rich fraction was incubated in a
plastic culture dish for 60 min with RPMI 1640 with
10 % FCS at 37C, 5 % CO2 to remove contaminat-
ing macrophages. Next, non-adhering cells were
transferred to new wells for a 6-h incubation in fresh
medium: RPMI 1640, 2 mM L-glutamine, 50 tM
2-mercaptoethanol, 100 U/ml penicillin, 100 ktg/ml
streptomycin, 5 % FCS. During this incubation, FDC
adhered weakly to the substrate. Non-adhering popu-
lation was carefully d,iscarded. The culture medium
was replaced once daily.
For immunohistochemistry, some FDC-clusters
were cultured on polylysine-coated glass coverslips in
6-well culture plates.
Immunohistochemistry
Cryosections (8-10 m) of tonsils and cytospins of
FDC-clusters (non-enzymatically isolated) were fixed
in acetone for 10 min at 4C. On the other hand, FDC
cultured on polylysine-coated glass coverslips for 4
days were fixed in paraformaldehyde 2 % for 10 min
at 4C.
Cryosections and cytospecimens were treated with
a non-specific rabbit serum for 15 min, then allowed
to react for 1 h at room temperature with MoAbs:
DRC1 (Dako, Denmark), 12F10, 3B5, 8G8 or 3F4
antibody at optimal dilution (1/100, 1/100, 1/100,
1/100 and 1/200 respectively). The preparations were
incubated with biotinylated rabbit anti-mouse immu-
noglobulin (trig, 1/200) for 1 h, followed by StrepAB
Complex HRP (Zymed). Peroxidase activity was
revealed with 9-ethyl-3-aminocarbazol (AEC) and
H20;z as substrates (Zymed). For the cryosections, we
used an amplification system (Envison kit, Dako,
Denmak) in place of the secondary antibody. All anti-
body dilutions and wash steps were performed in
phosphate buffered saline, pH 7.2 (supplemented with
0.5 % Tween for MoAb 3F4 dilution only).
Negative controls consisted of preparations in
which the specific antibody was replaced with
non-specific mouse serum and once from which the
primary antibody was omitted.
Flow-cytometric Analysis
After 6 days of culture, the FDC were checked for the
ability to effect B lymphocytes emperipolesis. This is
a reliable test for identifying FDC in vitro (Tsunoda et
al., 1992). Freshly prepared tonsillar B lymphocytes
were added to the monolayered FDC in vitro. Cul-
tured FDC can entrap lymphocytes beneath their
cytoplasm extensions (pscudoemperipolesis). Other
FDC that had been cultured for 6 days were harvested
by treatment with 0.25 % trypsin and 0.04 % ethylen-
ediamine tetra-acetic acid in PBS and washed. Some
detached FDC were stored in FCS on ice until immu-
nostaining. Others were cultured for 15 h at 37C as
cell suspensions in R_PMI containing 10 % FCS and
HEPES. This was done with the Techne(R) system
(Duxford Cambridge, UK) avoiding attachment to the
substrate. Thereafter, the cells were collected and
washed. Both types of FDC preparation were incu-
bated with biotinylated monoclonal antibody (8G8 or
3B5), followed by Streptavidin-Per-Cys (Dako, Den-
mark). Jurkat cells (human T-cell lymphoma-cell line)
constituted the positive control for PrPc. In the nega-
tive control, we used non-specific murine
IgG-Per-Cys (Dako, Denmark).
The fluorescence intensity was analyzed by means
of the Cell-Quest system with a FACScan flow
cytometer (Becton-Dickinson, USA).266 CAROLINE THIELEN et al.
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